首站-论文投稿智能助手
典型文献
He-Wei Granule enhances anti-tumor activity of cyclophosphamide by changing tumor microenvironment
文献摘要:
Objective:He-Wei Granule(HWKL)is a modern product derived from the modified formulation of traditional Chinese medicine Banxia Xiexin Decoction(BXD),which remarkedly enhanced the anti-proliferation activity of cyclophosphamide(CTX)on HepG2 and SGC-7901 cell lines in vitro in our previous research.The aim of the study was to investigate the synergistic effects of HWKL and CTX using a transplanted H22 hepatocellular carcinoma mouse model.Methods:The CTX-toxic-reducing efficacy of HWKL was evaluated by hematology indexes,organ indexes and marrow DNA detection.To investigate the underlying mechanisms,histopathology test,immunohis-tochemistry test and TUNEL staining were conducted.The efficacy of HWKL on the micro-vessel density(MVD)in tumor tissue was also evaluated by measuring CD34 level.Results:High dose HWKL(6.75 g/kg)markedly attenuated CTX-induced hepatotoxicity and myelosup-pression while significantly enhanced CTX anticancer efficacy in vivo.Further mechanism investigation suggested that high dose HWKL significantly increased cleaved Caspase 3 level and promoted apoptosis in tumor tissue by up-regulating Bax expression and down-regulating Bcl-2 and FasL expressions.Compared with CTX alone group,the decrease in LC-3B and Beclin 1 levels suggested that the autophagy in H22 carcinoma was significantly inhibited with addition of high dose HWKL.ELISA assay results indicated that the autophagy inhibition was achieved by decreasing p53 expression,blocking PI3K/AKT/mTOR pathway and recovering Th1/Th2 cytokine balance.In addition,CD34 and EGFR immunohistochemistry assay suggest that high dose HWKL could significantly decrease micro-vessel density(MVD)and inhibit angiogenesis in H22 carcinoma.Conclusion:It can be concluded that high-dose HWKL enhanced CTX efficacy by promoting apoptosis,inhibiting autophagy and angiogenesis in tumor tissue while significantly alleviated CTX-induced toxic-ity,and could be applied along with CTX in clinical treatment as a supplement agent.
文献关键词:
作者姓名:
Jianxiu Zhai;Zehai Song;Hang Chang;Yuwei Wang;Na Han;Zhihui Liu;Jun Yin
作者机构:
Key Laboratory of Northeast Plant Materials,Department of Pharmacognosy and Utilization,School of Traditional Chinese Medicine,Shenyang Pharmaceutical University,Shenyang 110016,China
引用格式:
[1]Jianxiu Zhai;Zehai Song;Hang Chang;Yuwei Wang;Na Han;Zhihui Liu;Jun Yin-.He-Wei Granule enhances anti-tumor activity of cyclophosphamide by changing tumor microenvironment)[J].中草药(英文版),2022(01):79-89
A类:
HWKL,immunohis,tochemistry,myelosup
B类:
Wei,Granule,enhances,tumor,activity,cyclophosphamide,by,changing,microenvironment,Objective,modern,product,derived,from,modified,formulation,traditional,Chinese,medicine,Banxia,Xiexin,Decoction,BXD,which,remarkedly,enhanced,proliferation,CTX,HepG2,SGC,lines,vitro,our,previous,research,aim,study,was,investigate,synergistic,effects,using,transplanted,H22,hepatocellular,carcinoma,mouse,model,Methods,reducing,efficacy,evaluated,hematology,indexes,organ,marrow,detection,To,underlying,mechanisms,histopathology,test,TUNEL,staining,were,conducted,vessel,density,MVD,tissue,also,measuring,CD34,Results,High,dose,attenuated,induced,hepatotoxicity,while,significantly,anticancer,vivo,Further,investigation,suggested,that,high,increased,cleaved,Caspase,promoted,apoptosis,regulating,Bax,down,Bcl,FasL,expressions,Compared,alone,group,decrease,LC,3B,Beclin,levels,autophagy,inhibited,addition,assay,results,indicated,inhibition,achieved,decreasing,p53,blocking,PI3K,AKT,mTOR,pathway,recovering,Th1,Th2,cytokine,balance,In,EGFR,immunohistochemistry,could,angiogenesis,Conclusion,It,be,concluded,promoting,inhibiting,alleviated,applied,along,clinical,treatment,supplement,agent
AB值:
0.518164
相似文献
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
Jingrong Xian;Shiwen Wang;Yanyu Jiang;Lihui Li;Lili Cai;Ping Chen;Yue Liu;Xiaofei Zeng;Guoan Chen;Chen Ding;Robert M.Hoffman;Lijun Jia;Hu Zhao;Yanmei Zhang-Department of Laboratory Medicine,Huadong Hospital Affiliated to Fudan University,Shanghai 200040,China;Cancer Institute,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Research Center on Aging and Medicine,Fudan University,Shanghai 200040,China;Shanghai Key Laboratory of Clinical Geriatric Medicine,Shanghai 200040,China;Department of Basic Science of Oncology,College of Basic Medical Sciences,Zhengzhou University,Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;School of Medicine,Southern University of Science and Technology,Shenzhen 518055,China;State Key Laboratory of Genetic Engineering,Human Phenome Institute,Institutes of Biomedical Sciences,School of Life Sciences,Zhongshan Hospital,Fudan University,Shanghai 200032,China;State Key Laboratory of Cell Differentiation and Regulation,Henan International Joint Laboratory of Pulmonary Fibrosis,Henan Center for Outstanding Overseas Scientists of Pulmonary Fibrosis,College of Life Science,Institute of Biomedical Science,Henan Normal University,Xinxiang 453007,China;Department of Surgery,University of California,San Diego 92101,USA;Anticancer Inc.,San Diego 92101,USA
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Autophagy, not apoptosis, plays a role in lumen formation of eccrine gland organoids
Du Lijie;Zhang Lei;Zhao Junhong;Chen Zixiu;Liu Xiang;Cao Manxiu;You Lei;Zhang Yonghong;Fu Xiaobing;Li Haihong-Department of Wound Repair and Dermatologic Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China;Hubei Clinical Medical Research Center of Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China;Mental Health Center, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China;School of Basic Medicine, Academy of Bio-Medicine Research, Hubei University of Medicine, Shiyan, Hubei 442000, China;Wound Healing and Cell Biology Laboratory, The First Affiliated Hospital, Chinese PLA General Hospital, Beijing 100048, China
Effect of moxibustion on autophagy and the inflammatory response of synovial cells in rheumatoid arthritis model rats
HAO Feng;WANG Qiang;LIU Lei;WU Libin;CAI Ronglin;SANG Jiajia;HU Jun;WANG Jie;YU Qing;HE Lu;SHEN Yingchao;MIAO Yiming;HU Ling;WU Zijian-College of Acupuncture-moxibustion and Tuina,Nanjing University of Chinese Medicine,Nanjing 210023,China;Translational Medicine Research Center of Nanjing University of Chinese Medicine,Nanjing 210023,China;Changshu Hospital Affiliated to Nanjing University of Chinese Medicine,Changshu 215500,China;College of Acupuncture-moxibustion and Tuina,Anhui University of Chinese Medicine,Hefei 230012,China;Institute of Acupuncture and Meridian,Anhui Academy of Chinese Medicine,Hefei 230038,China;Affiliate Hospital of Nanjing University of Chinese Medicine/Jiangsu Province of Chinese Medicine, Nanjing 210029, China;the first clinical medical college of Nanjing University of Chinese Medicine,Nanjing 210029,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。